Bain Capital Life Sciences Investors as of Dec. 31, 2019
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 10 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 41.8 | $280M | 7.3M | 38.49 | |
| Constellation Pharmceticls I | 19.8 | $133M | 2.8M | 47.11 | |
| Dicerna Pharmaceuticals | 13.4 | $90M | 4.1M | 22.03 | |
| Dynavax Technologies (DVAX) | 7.2 | $48M | 8.5M | 5.72 | |
| Replimune Group (REPL) | 6.1 | $41M | 2.8M | 14.35 | |
| Savara (SVRA) | 3.4 | $23M | 5.1M | 4.48 | |
| X4 Pharmaceuticals (XFOR) | 2.6 | $18M | 1.6M | 10.70 | |
| Solid Biosciences | 2.6 | $17M | 3.9M | 4.45 | |
| Marinus Pharmaceuticals | 1.9 | $13M | 5.9M | 2.16 | |
| Aptinyx | 1.1 | $7.6M | 2.2M | 3.42 |
